Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Long R3 IGF-1 vs IGF-1 LR3: Structural Comparison

Amino Acid Length 83 residues 70 residues The 13-residue N-terminal extension in Long R3 is the primary structural modification. Not a post-translational addition but a designed sequence extension Position 3 Residue Arginine (Arg) Glutamic Acid (Glu) This sing

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Amino Acid Length
  • 83 residues
  • 70 residues
  • The 13-residue N-terminal extension in Long R3 is the primary structural modification. Not a post-translational addition but a designed sequence extension
  • Position 3 Residue
  • Arginine (Arg)
  • Glutamic Acid (Glu)
  • This single substitution reduces IGFBP-3 binding affinity by 10–20-fold, critical for extended in vitro stability
  • IGFBP Binding Affinity
  • Reduced 100-fold vs native IGF-1
  • High affinity for all six IGFBPs
  • The functional consequence: Long R3 remains bioavailable in serum-containing media where native IGF-1 would be sequestered within minutes
  • Functional Half-Life (cell culture)
  • 15–20 hours
  • <10 minutes
  • This allows once-daily dosing in multi-day protocols without media replacement. Native IGF-1 requires dosing every 2–4 hours
  • IGF-1 Receptor Affinity
  • Equivalent to native IGF-1
  • Baseline (100%)
  • The structural modifications do not reduce receptor engagement. Signaling potency remains unchanged
  • CAS Registry Number
  • 946870-92-4
  • 67763-96-6
  • Use CAS numbers for definitive product verification. Naming conventions vary, molecular structure does not